NDC00173-0449-02: SUMATRIPTAN SUCCINATE INJECTION.
SUMATRIPTAN SUCCINATE INJECTION. Key specifications include primary_container_type: VIAL, SINGLE DOSE, therapeutic_equivalent: TO IMITREX BY GLAXO, primary_container_content_quantity: 2.000 MILLILITERS, active_medicament_medicinal_strength: 6.000 MILLIGRAMS SUMATRIPTAN SUCCINATE PER 0.5 MILLILITERS, part_name_assigned_by_controlling_agency: SUMATRIPTAN SUCCINATE INJECTION 6MG/0.5ML 2ML VIAL 5S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-374-5874, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| primary_container_type | VIAL, SINGLE DOSE |
| therapeutic_equivalent | TO IMITREX BY GLAXO |
| total_primary_container_quantity | 5 |
| primary_container_content_quantity | 2.000 MILLILITERS |
| active_medicament_medicinal_strength | 6.000 MILLIGRAMS SUMATRIPTAN SUCCINATE PER 0.5 MILLILITERS |
| part_name_assigned_by_controlling_agency | SUMATRIPTAN SUCCINATE INJECTION 6MG/0.5ML 2ML VIAL 5S |
| NSN | 6505-01-374-5874 |
| THERAPEUTIC EQUIVALENT | TO IMITREX BY GLAXO |
| PRIMARY CONTAINER CONTENT QUANTITY | 2.000 MILLILITERS |
| PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | SUMATRIPTAN SUCCINATE INJECTION 6MG/0.5ML 2ML VIAL 5S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 6.000 MILLIGRAMS SUMATRIPTAN SUCCINATE PER 0.5 MILLILITERS |
| TOTAL PRIMARY CONTAINER QUANTITY | 5 |